BNET Industries

Last Fiscal Year Sales:$30.9M
  • Public
  • US
Dow Jones Description

Endocrine and metabolic diseases pose unique challenges to the scientific and clinical communities. Patients afflicted with these conditions often face great compromises in their quality of life, and they look to the innovators in biomedical science to offer new, more effective treatments. At Tercica, we take our responsibility to these patients very seriously, and we recognize that important advances are most likely to result when we share knowledge and resources. By fostering strategic partnerships with leading biopharmaceutical companies like Genentech and Ipsen SA, Tercica has already succeeded in bringing two novel products to market. Today, we continue to pursue partnerships with the scientific and clinical communities to develop promising new therapies that help many patients to live fuller, healthier lives.

Number of Employees 126
Contact Information

2000 Sierra Point Pkwy Ste 400

Brisbane, California 94005-1849

www.tercica.com

(650) 624-4900

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

merger and tercica inc. - All News and Analysis

advertisement